|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/31 | |
| A61P 11/00 | |||
| A61P 31/06 | |||
| A61P 31/04 | |||
| A61P 7/00 | |||
| A61P 9/00 | |||
| A61P 13/00 | |||
| A61P 15/00 | |||
| A61P 17/00 | |||
| A61P 19/00 |
| (11) | Number of the document | 2188016 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08802149.8 |
| Date of filing the European patent application | 2008-09-09 | |
| (97) | Date of publication of the European application | 2010-05-26 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/007598 |
| Date | 2008-09-09 |
| (87) | Number | WO 2009/033722 |
| Date | 2009-03-19 |
| (30) | Number | Date | Country code |
| 07017752 | 2007-09-11 | EP |
| (72) |
BEVEC, Dorian, DE
CAVALLI, Fabio, CH
CAVALLI, Vera, CH
BACHER, Gerald, DE
|
| (73) |
Mondobiotech Laboratories AG,
Herrengasse 21, 9490 Vaduz,
LI
|
| (54) | USE OF OCTREOTIDE AS A THERAPEUTIC AGENT |
| USE OF OCTREOTIDE AS A THERAPEUTIC AGENT |